LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 4,000 | 3,000 | 0 | 0 | 0 |
| Gross Profit | 4,000 | 3,000 | 0 | 0 | 0 |
| Operating Expenses | 14,580 | 12,194 | 8,123 | 5,477 | 3,801 |
| Operating Income | -10,580 | -9,194 | -8,123 | -5,477 | -3,801 |
| Interest Expense | 180 | 301 | 145 | 0 | 0 |
| Other Income | 1,170 | 941 | 321 | 705 | 475 |
| Pre-tax Income | -9,590 | -8,554 | -7,947 | -4,772 | -3,326 |
| Net Income Continuous | -9,596 | -8,554 | -7,947 | -4,772 | -3,326 |
| Net Income | $-9,590 | $-8,554 | $-7,947 | $-4,772 | $-3,326 |
| EPS Basic Total Ops | -1,575,000.00 | -1,975,000.00 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1,575,985.00 | -1,975,000.00 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1,575,000.00 | -1,975,000.00 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1,575,985.00 | -1,975,000.00 | N/A | N/A | N/A |
| EBITDA(a) | $-9,640 | $-8,410 | $-7,667 | $-5,159 | $-3,623 |